During the last session, Sage Therapeutics Inc (NASDAQ:SAGE)’s traded shares were 2.87 million, with the beta value of the company hitting 0.17. At the end of the trading day, the stock’s price was $9.13, reflecting an intraday gain of 0.11% or $0.01. The 52-week high for the SAGE share is $13.47, that puts it down -47.54 from that peak though still a striking 49.4% gain since the share price plummeted to a 52-week low of $4.62. The company’s market capitalization is $571.73M, and the average trade volume was 1.43 million shares over the past three months.
Sage Therapeutics Inc (SAGE) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 2.88. SAGE has a Sell rating from 1 analyst(s) out of 8 analysts who have looked at this stock. 4 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.
Sage Therapeutics Inc (NASDAQ:SAGE) trade information
Sage Therapeutics Inc (SAGE) registered a 0.11% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.11% in intraday trading to $9.13, hitting a weekly high. The stock’s 5-day price performance is 34.86%, and it has moved by 29.14% in 30 days. Based on these gigs, the overall price performance for the year is -23.92%.
The consensus price target of analysts on Wall Street is $7, which implies a decrease of -30.43% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5 and $9 respectively. As a result, SAGE is trading at a premium of 1.42% off the target high and 45.24% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 13.20%. While earnings are projected to return 46.38% in 2025, the next five years will return 35.78% per annum.
SAGE Dividends
Sage Therapeutics Inc is due to release its next quarterly earnings on 2025-Apr-29. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 5.82 million shares, is of FMR LLC’s that is approximately 9.6193% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $63.24 million.
